IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1
-- Advancing IGC-AD1 Toward Commercialization as a Treatment for Agitation in Alzheimer's -- ...
Source: marketscreener.com
Stay updated with breaking news from Neurostudies Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-- Advancing IGC-AD1 Toward Commercialization as a Treatment for Agitation in Alzheimer's -- ...